MNKD Mannkind Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: MNKD

Price (delayed)

$4.22

Market cap

$1.14B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.04

Enterprise value

$1.42B

MannKind Corporation focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, its ...

Highlights
The revenue has soared by 99% YoY and by 13% from the previous quarter
Mannkind's EPS has soared by 88% YoY and by 67% from the previous quarter
The company's debt rose by 34% QoQ and by 34% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.mannkindcorp.com/
Peers: HALO NKTR LLY PFE

Key stats

What are the main financial stats of MNKD
Market
Shares outstanding
270.42M
Market cap
$1.14B
Enterprise value
$1.42B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
5.66
EV/EBIT
95.74
EV/EBITDA
68.65
EV/Sales
7.11
Earnings
Revenue
$198.96M
EBIT
$14.78M
EBITDA
$20.62M
Free cash flow
-$8.35M
Per share
EPS
-$0.04
Free cash flow per share
-$0.03
Book value per share
-$0.91
Revenue per share
$0.75
TBVPS
$1.77
Balance sheet
Total assets
$475.2M
Total liabilities
$721.37M
Debt
$512.81M
Equity
-$246.17M
Working capital
$269.27M
Liquidity
Debt to equity
-2.08
Current ratio
3.59
Quick ratio
2.98
Net debt/EBITDA
13.3
Margins
EBITDA margin
10.4%
Gross margin
68.5%
Net margin
-6%
Operating margin
5.3%
Efficiency
Return on assets
-3.4%
Return on equity
N/A
Return on invested capital
2.7%
Return on capital employed
4%
Return on sales
7.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MNKD stock price

How has the Mannkind stock price performed over time
Intraday
0.96%
1 week
0.96%
1 month
-14.05%
1 year
10.18%
YTD
15.93%
QTD
-6.84%

Financial performance

How have Mannkind's revenue and profit performed over time
Revenue
$198.96M
Gross profit
$136.19M
Operating income
$10.59M
Net income
-$11.94M
Gross margin
68.5%
Net margin
-6%
MNKD's operating margin has surged by 200% since the previous quarter and by 108% year-on-year
MNKD's operating income has soared by 115% YoY
The revenue has soared by 99% YoY and by 13% from the previous quarter
The company's net margin has surged by 93% YoY and by 66% QoQ

Growth

What is Mannkind's growth rate over time

Valuation

What is Mannkind stock price valuation
P/E
N/A
P/B
N/A
P/S
5.66
EV/EBIT
95.74
EV/EBITDA
68.65
EV/Sales
7.11
Mannkind's EPS has soared by 88% YoY and by 67% from the previous quarter
The equity has increased by 2.2% since the previous quarter
The revenue has soared by 99% YoY and by 13% from the previous quarter
The P/S is 40% lower than the 5-year quarterly average of 9.4 and 15% lower than the last 4 quarters average of 6.6

Efficiency

How efficient is Mannkind business performance
The company's return on invested capital has surged by 124% YoY
Mannkind's ROS has soared by 112% YoY
The ROA has soared by 88% YoY and by 67% QoQ

Dividends

What is MNKD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MNKD.

Financial health

How did Mannkind financials performed over time
The company's total assets is 34% lower than its total liabilities
Mannkind's quick ratio has surged by 76% QoQ and by 7% YoY
The company's total assets has surged by 61% YoY and by 48% QoQ
The debt to equity is down by 37% since the previous quarter and by 36% year-on-year
The company's debt rose by 34% QoQ and by 34% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.